梅花生物部分高管拟增持3.04亿元至3.5亿元公司股份

Core Viewpoint - Meihua Biological (600873.SH) announced that a total of 76 members, including some directors, senior management, and other core management personnel, plan to increase their shareholding in the company through the secondary market starting from January 14, 2026, for a period not exceeding 12 months [1] Group 1 - The total amount for the planned share buyback is set to be no less than 304 million yuan (including transaction fees) and no more than 350 million yuan (including transaction fees) [1] - The share buyback price will be determined based on market conditions, and there is no upper limit set for the buyback price [1]